Published on Sep 14, 2016
The deal is the largest corporate takeover in almost two decades for a German company. German pharmaceuticals giant Bayer has agreed to buy American GMO company Monsanto for $128 a share. The acquisition values Monsanto’s equity at about $56 billion, but including debt, the deal is worth nearly $66 billion. The acquisition of the leading GMO maker will make Bayer the world’s biggest seed and pesticide producer. Robert Verkerk and Peter Oliver talk to RT on the matter.